Therapy by intrathecal administration of antitumor agent FUDR

Details Therapy by intrathecal administration of antitumor agent FUDR Therapy by intrathecal administration of antitumor agent FUDR

1997-01-27

2000-10-31

Jordan, Kimberly

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Carbohydrate doai

A61K 3170

Patent

active

061403113

ABSTRACT:
The invention relates to a novel method of treating malignant brain tumors and meningeal dissemination of malignant tumors by intrathecally giving FUDR, an antitumor agent, to produce an outstanding therapeutic effect selectively on the tumor cells with safety.

REFERENCES:
patent: 5455044 (1995-10-01), Kim et al.
Cancer vol. 68, 995-998 (1991)-B.Damascelli et al.

Affiliated with

Also associated with

Rating

Therapy by intrathecal administration of antitumor agent FUDR does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Therapy by intrathecal administration of antitumor agent FUDR, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Therapy by intrathecal administration of antitumor agent FUDR will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2051906